Trial | NCT00713674  Report issue

Title

Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
Comparison of Decolonization of MRSA Using Theraworx

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Withdrawn

  • Study Participants

    0
The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.
Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.
Study Started
Mar 31
2008
Primary Completion
Feb 28
2009
Study Completion
Feb 28
2009
Last Update
Mar 23
2017

Other Theraworx

Theraworx swab intranasal BID for 5 days

Drug mupirocin antibiotic ointment

mupirocin antibiotic ointment swab intranasal BID for 5 days

3 Active Comparator

mupirocin antibiotic ointment intranasal

1 No Intervention

No Treatment

2 Experimental

Theraworx intranasal

Criteria 

Inclusion Criteria:

Positive MRSA culture

Exclusion Criteria:

Patients currently on or start antibiotic therapy directed for MRSA.(Prophylaxis antibiotic for surgical procedure not considered therapy.)
Patients with MRSA infected wounds
Patients under the age of 18 years
A woman currently pregnant or nursing a child
Patients participating in another study within 30 days of randomization
No Results Posted